Senzo Secures an Additional $1.8m Investment for Its Novel Rapid Home-Test Diagnostic Platform
Senzo Health Limited (London, UK) ("Senzo"), a life sciences company developing high-accuracy, low-cost, point-of-care diagnostic technologies, this week announced an additional $1.8m investment for its...
Gemina Laboratories to Host Investor Webinar on March 30, 2023
VANCOUVER, BC / ACCESSWIRE / March 27, 2023 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce that it will host...
Senzo and Abingdon Health Enter Into Strategic Partnership
Abingdon Health's CDMO service to support Senzo in leveraging its innovative, high-accuracy Amplified Lateral Flow (ALF) point-of-care diagnostics platform technology across multiple product opportunities. Senzo...
Senzo Secures Additional $1.9MM Equity Funding for Its PCR-Accurate Lateral Flow Test
The funding, led by existing investors BioAdvance and Wellness Coaches, follows additional 3rd party studies by University College London and LateralDx, confirming that Senzo's Amplified...